^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
rhIL-15
i
Other names: rhIL-15
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
National Cancer Institute
Drug class:
CD8 T-cell agonist, CD4 T cell modulator
Related drugs:
